Page last updated: 2024-08-17

2,3,5-triiodobenzoic acid and Carcinoma, Non-Small Cell Lung

2,3,5-triiodobenzoic acid has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
de Abreu, JSS; Fernandes, J	1

Other Studies

1 other study(ies) available for 2,3,5-triiodobenzoic acid and Carcinoma, Non-Small Cell Lung

Article	Year
The contrast agent 2,3,5-triiodobenzoic acid (TIBA) induces cell death in tumor cells through the generation of reactive oxygen species. Molecular biology reports, 2021, Volume: 48, Issue:6 Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line, Tumor; Cell Survival; Chlorocebus aethiops; Contrast Media; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Neoplasms; Oxidative Stress; Reactive Oxygen Species; Triiodobenzoic Acids; Vero Cells	2021

Article

Year

The contrast agent 2,3,5-triiodobenzoic acid (TIBA) induces cell death in tumor cells through the generation of reactive oxygen species.

Molecular biology reports, 2021, Volume: 48, Issue:6

Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line, Tumor; Cell Survival; Chlorocebus aethiops; Contrast Media; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Neoplasms; Oxidative Stress; Reactive Oxygen Species; Triiodobenzoic Acids; Vero Cells

2021